CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Pulik Richard CFO | Option exercise | +127,365 | $3.85 | $490K | 397,046 |
| 2026-11-11 | Pulik Richard CFO | Sale | −45,195 | $41.47 | $1.9M | 351,851 |
| 2026-11-11 | Pulik Richard CFO | Sale | −82,170 | $42.03 | $3.5M | 269,681 |
| 2026-11-11 | Pulik Richard CFO | Sale | −47,635 | $41.89 | $2.0M | 222,046 |
| 2026-11-11 | Pulik Richard CFO | Option exercise · Stock Option (Right to Buy) | −127,365 | 487,635 | ||
| 2026-11-10 | Pulik Richard CFO | Option exercise | +125,000 | $3.85 | $481K | 394,681 |
| 2026-11-10 | Pulik Richard CFO | Sale | −125,000 | $41.20 | $5.2M | 269,681 |
| 2026-11-10 | Pulik Richard CFO | Option exercise · Stock Option (Right to Buy) | −125,000 | 615,000 | ||
| 2026-09-20 | Pulik Richard CFO | Shares withheld for taxes | −2,129 | $39.77 | $85K | 269,681 |
| 2026-08-20 | Pulik Richard CFO | Shares withheld for taxes | −5,749 | $36.84 | $212K | 271,810 |
| 2026-06-20 | Pulik Richard CFO | Shares withheld for taxes | −2,129 | $31.43 | $67K | 276,420 |
| 2026-05-20 | Pulik Richard CFO | Shares withheld for taxes | −18,962 | $32.41 | $615K | 278,549 |
| 2026-04-20 | Pulik Richard CFO | Grant or award | +60,644 | 297,511 | ||
| 2026-04-20 | Pulik Richard CFO | Grant or award · Stock Option (Right to Buy) | +84,026 | 84,026 | ||
| 2026-03-20 | Pulik Richard CFO | Shares withheld for taxes | −1,546 | $27.70 | $43K | 236,867 |
| 2026-02-20 | Pulik Richard CFO | Shares withheld for taxes | −1,000 | $27.15 | $27K | 238,413 |
| 2025-12-23 | Pulik Richard CFO | Option exercise | +260,000 | $3.85 | $1.0M | 646,144 |
| 2025-12-23 | Pulik Richard CFO | Sale | −260,000 | $22.45 | $5.8M | 386,144 |
| 2025-12-23 | Pulik Richard CFO | Sale | −146,731 | $22.39 | $3.3M | 239,413 |
| 2025-12-23 | Pulik Richard CFO | Option exercise · Stock Option (Right to Buy) | −260,000 | 740,000 |
Page 1 of 3 · 44 trades